down arrow

Everest Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
303.00
-9.85 (-3.15%)
BSENSE

Apr 11, 12:49 PM

BSE+NSE Vol: 2.08 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Gennex Lab.
Cipla
Everest Organics
Sun Pharma.Inds.
Torrent Pharma
Trident Lifeline
Oxygenta Pharma
Ambalal Sarabhai
Sanjiv.Parant.
Mankind Pharma
Why is Everest Organics Ltd ?
1
Weak Long Term Fundamental Strength with a -50.40% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.02 times
2
Positive results in Dec 24
  • OPERATING PROFIT TO INTEREST(Q) Highest at 2.87 times
  • PBDIT(Q) Highest at Rs 4.02 cr.
  • OPERATING PROFIT TO NET SALES(Q) Highest at 9.56%
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 03-Apr-25 and has generated 11.43% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
4
With ROCE of -0.6, it has a Very Expensive valuation with a 3.9 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 136.61%, its profits have fallen by -433%
5
Majority shareholders : Promoters
6
Market Beating performance in long term as well as near term
  • Along with generating 136.61% returns in the last 1 year, the stock has outperformed BSE 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Everest Organics should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Drugs should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Everest Organics for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Everest Organics
136.53%
2.19
62.28%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-0.21%
EBIT Growth (5y)
-50.40%
EBIT to Interest (avg)
1.58
Debt to EBITDA (avg)
14.75
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.10
Tax Ratio
2.73%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
3.41%
ROE (avg)
11.49%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
7.50
EV to EBIT
354.40
EV to EBITDA
52.43
EV to Capital Employed
3.89
EV to Sales
2.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.64%
ROE (Latest)
-10.22%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

Highest at 2.87 times

PBDIT(Q)

Highest at Rs 4.02 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 9.56%

PBT LESS OI(Q)

Highest at Rs 1.15 cr.

PAT(Q)

Highest at Rs 1.14 cr.

EPS(Q)

Highest at Rs 1.43

-1What is not working for the Company
NET SALES(Q)

At Rs 42.05 cr has Fallen at -7.4% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Everest Organics
Operating Profit to Interest - Quarterly
Highest at 2.87 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit (PBDIT) - Quarterly
Highest at Rs 4.02 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 9.56%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.15 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 1.14 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 1.43
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Everest Organics
Net Sales - Quarterly
At Rs 42.05 cr has Fallen at -7.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 45.41 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)